Drug
Buprenorphine Naloxone
Buprenorphine Naloxone: highest development phase Post-Market, developed by Indivior. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| 2.0mg Buprenorphine/0.5mg Naloxone NCT01846455 | Post-Market | Hepatic Failure |
Latest
No recent events.
Follow Buprenorphine Naloxone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.